SCHEMBL5504594

SCHEMBL5504594

CCOC(=O)C1=C2C=C3CC3=C2C=C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
ALOX15 P16050 1/20 0.37
KMT2A Q03164 1/20 0.37
TSHR P16473 1/20 0.36
ALDH1A1 P00352 6/20 0.35
HPGD P15428 4/20 0.35
HTT P42858 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
HSP90AA1 P07900 1/20 0.35
CACNA1B Q00975 1/20 0.35
APBA1 Q02410 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CA12 O43570 4/20 0.34
CA1 P00915 4/20 0.34
CA2 P00918 4/20 0.34
CA7 P43166 4/20 0.34
CA9 Q16790 4/20 0.34
CA14 Q9ULX7 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL819237 0.65 TSHR (0.50) MAPTKDM4EMEN1ALOX15KMT2A
SCHEMBL7563364 0.64 TSHR (0.40) MAPTMEN1KMT2ATSHRALDH1A1
SCHEMBL1831583 0.62 MAPT (0.40) MAPTKDM4EMEN1ALOX15KMT2A
SCHEMBL817678 0.62 TSHR (0.43) MAPTKDM4EMEN1ALOX15KMT2A
SCHEMBL28732750 0.61 KDM4E (0.42) MAPTKDM4EMEN1ALOX15KMT2A
SCHEMBL9548196 0.61 KDM4E (0.72) MAPTKDM4EMEN1ALOX15KMT2A
SCHEMBL303623 0.61
SCHEMBL818676 0.60 LMNA (0.44) MAPTKDM4EMEN1KMT2ATSHR
SCHEMBL819019 0.59 KDM4E (0.44) MAPTKDM4EMEN1ALOX15KMT2A
SCHEMBL12808756 0.59 MEN1 (0.43) MAPTKDM4EMEN1ALOX15KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831178-A2 FUSED PYRAZOLE DERIVATIVES AND USES THEREOF IN METHODS OF TREATMENT OF METABOLIC-RELATED DISORDERS Arena Pharmaceuticals, Inc. (US) 2007-09-12 EP disclosed
WO-2006069242-A2 FUSED PYRAZOLE DERIVATIVES AND USES THEREOF IN METHODS OF TREATMENT OF METABOLIC-RELATED?DISORDERS ARENA PHARMACEUTICALS, INC. (US) 2006-06-29 WO disclosed